1. Home
  2. SLN vs LOVE Comparison

SLN vs LOVE Comparison

Compare SLN & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$7.13

Market Cap

236.2M

Sector

Health Care

ML Signal

HOLD

Logo The Lovesac Company

LOVE

The Lovesac Company

HOLD

Current Price

$15.28

Market Cap

193.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLN
LOVE
Founded
1994
1998
Country
United Kingdom
United States
Employees
116
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
236.2M
193.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SLN
LOVE
Price
$7.13
$15.28
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$42.60
$25.00
AVG Volume (30 Days)
303.7K
189.8K
Earning Date
05-07-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.28
Revenue
N/A
$697,115,000.00
Revenue This Year
N/A
$4.63
Revenue Next Year
N/A
$6.40
P/E Ratio
N/A
$54.43
Revenue Growth
N/A
2.42
52 Week Low
$4.19
$10.33
52 Week High
$8.40
$21.06

Technical Indicators

Market Signals
Indicator
SLN
LOVE
Relative Strength Index (RSI) 51.08 47.80
Support Level $5.91 $14.04
Resistance Level $7.21 $15.44
Average True Range (ATR) 0.47 0.59
MACD -0.11 -0.19
Stochastic Oscillator 34.77 30.89

Price Performance

Historical Comparison
SLN
LOVE

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

Share on Social Networks: